SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Johnson Pharmacare informs about outcome of board meeting

27 Oct 2025 Evaluate
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Johnson Pharmacare has informed that the Board of Directors of the Company, in their meeting held on today Monday 27th October 2025 at the Registered Office of the Company and transacted the following major business: The board has considered and accepted the resignation of Paresh Sengal from the post of Director of the Company with effect from 27.10.2025. The board meeting commenced at 04:00 pm and concluded at 04:30 pm.

The above information is a part of company’s filings submitted to BSE.  

Johnson Pharmacare Share Price

0.60 0.00 (0.00%)
24-Apr-2026 09:50 View Price Chart
Peers
Company Name CMP
Redington 217.50
Adani Enterprises 2260.60
Amrapali Industries 17.88
Rashi Peripheral 475.30
PDS 281.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×